Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fondaparinux Trial with UFH during Revascularization in Acute Coronary Syndromes (FUTURA)
2008-002747-16Phase 4Completed
- Sponsor
- GSK
- Start
- Sep 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fondaparinux and heparin in unstable angina and Non-ST-segment elevation myocardial infarction (NSTEMI) (2 arms), sponsored by GSK. Primary endpoints: Primary safety outcome and Net clinical benefit. Started Sep 2008; status: completed.
02
Drugs
fondaparinuxheparin
03
Conditions
unstable anginaNon-ST-segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on 2008-002747-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002747-16.